" class="no-js "lang="en-US"> Simon Stevens Archives - Medtech Alert
Thursday, May 23, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs

NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]

Researchers Behind Lifesaving Astra-Zeneca Jab Named Winners Of NHS Gong

Research teams at Oxford University who joined forces to fight coronavirus by developing a covid […]

NHS Chief Hails ‘Unprecedented’ Honour For Staff

Sir Simon Stevens today hailed the “skill and compassion and the fortitude” of health service […]

NHS Launches Online Service to Find Nearest Walk-in Jab Site

The NHS COVID-19 Vaccination programme, the biggest in health service history, today launched a new […]

my mhealth and University of Southampton announced as Round 2 Winner of The Artificial Intelligence in Health and Care Award

my mhealth Limited and the University of Southampton have been announced as a winner of […]

Over One Million Jabs Booked as NHS Vaccine Programme Opens to All Adults

More than one million jab appointments were booked since the NHS vaccination programme opened for […]

£36 Million Boost for AI Technologies to Revolutionise NHS Care

New technology will help detect cancers and provide mental health support Projects are part of […]

Half a Million COVID Jabs Booked in ‘Glastonbury Rush’ This Morning

The NHS saw a welcome surge in demand for vaccines this morning as half a […]

NHS Treats First Patient with the ‘World’s Most Expensive Drug’

A five-month old baby has become the first patient to receive a potentially life-saving drug […]

60 Million Doses of Covid-19 Vaccine Administered in UK

Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more